SBK Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$351K Sell
1,342
-47
-3% -$12K 0.17% 63
2026
Q2
$350K Buy
1,389
+197
+17% +$42.4K 0.23% 65
2026
Q1
$259K Buy
+1,192
New +$264K 0.22% 70
2022
Q1
– Sell
-900
Closed -$122K – 72
2021
Q4
$122K Buy
+900
New +$106K 0.1% 84

Other funds holding ABBV

SBK Financial's ABBV Position: Q3 2026 in Review

SBK Financial reduced its AbbVie (ABBV) stake by 3.4% in Q3 2026, selling an estimated $12K and leaving 1,342 shares worth $351K. The position accounts for 0.17% of the portfolio, ranked #63.

SBK Financial first reported a position in ABBV in Q4 2021 and has held it in 4 quarters since. 4,252 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • SBK Financial held 1,342 shares of AbbVie worth $351K as of Q3 2026.
  • SBK Financial sold 47 AbbVie shares in Q3 2026, an estimated $12K.
  • AbbVie made up 0.17% of SBK Financial's portfolio in Q3 2026, its #63 holding.
  • SBK Financial first reported a position in AbbVie in Q4 2021 and has held it in 4 quarters since.
  • 4,252 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on SBK Financial's 13F filing for Q3 2026, filed 2 Nov 2026.